Genedata AG-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Genedata AG - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014072
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:27
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スイス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Genedata AG (Genedata) is a healthcare technology company that transforms data into software solutions. The company delivers enterprise solutions for data analytics that streamline research and development workflows and improve research productivity. Its products include genedata biologics, genedata screener, genedata expressionist, genedata philosopher, genedata analyst and genedata selector. Genedata provides services such as information technology services, data analysis, custom software development, training, and hosting. The company also offers support and training services. It serves pharma, bio-pharma, agribusiness, industrial biotech, food and beverage, and other sectors. The company has presence in Switzerland, Germany, the US and Japan. Genedata is headquartered in Basel, Switzerland.

Genedata AG – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Genedata AG, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Genedata AG, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Genedata AG, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Genedata AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Genedata AG, Medical Devices Deals, 2011 to YTD 2017 9
Genedata AG, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Genedata AG, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Genedata Enters into Integration Agreement with IntelliCyt 11
Ab Sciex, Genedata And Leco Enter Into Agreement For Metabolomics Data Analysis Solution 12
Genedata Enters Into Technology Integration Agreement With Life Technologies 13
Licensing Agreements 14
F-star Biotech Enters into Licensing Agreement with Genedata 14
Genedata Enters into Licensing Agreement with Pfizer 15
Ono Pharma Enters Into Licensing Agreement With Genedata For Genedata Expressionist 16
Takeda Expands Licensing Agreement With Genedata For Genedata Expressionist 17
Roche Extends Licensing Agreement With Genedata 18
Chugai Pharma Extends Licensing Agreement With Genedata For Genedata Expressionist Software 19
Genedata Expands Licensing Agreement with MorphoSys 20
Takeda Expands Licensing Agreement With Genedata For Proteomics And Metabolomics Experiments 21
Genedata AG – Key Competitors 22
Genedata AG – Key Employees 23
Genedata AG – Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Recent Developments 25
Strategy And Business Planning 25
Feb 21, 2017: Genedata Expands Into United Kingdom 25
Product News 26
Jun 06, 2017: Genedata Announces New Solution for Efficient Analysis of High-Throughput Automated Patch Clamp Experiments 26
Appendix 27
Methodology 27
About GlobalData 27
Contact Us 27
Disclaimer 27

List of Tables
Genedata AG, Pharmaceuticals & Healthcare, Key Facts 2
Genedata AG, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Genedata AG, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Genedata AG, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Genedata AG, Deals By Therapy Area, 2011 to YTD 2017 8
Genedata AG, Medical Devices Deals, 2011 to YTD 2017 9
Genedata AG, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Genedata Enters into Integration Agreement with IntelliCyt 11
Ab Sciex, Genedata And Leco Enter Into Agreement For Metabolomics Data Analysis Solution 12
Genedata Enters Into Technology Integration Agreement With Life Technologies 13
F-star Biotech Enters into Licensing Agreement with Genedata 14
Genedata Enters into Licensing Agreement with Pfizer 15
Ono Pharma Enters Into Licensing Agreement With Genedata For Genedata Expressionist 16
Takeda Expands Licensing Agreement With Genedata For Genedata Expressionist 17
Roche Extends Licensing Agreement With Genedata 18
Chugai Pharma Extends Licensing Agreement With Genedata For Genedata Expressionist Software 19
Genedata Expands Licensing Agreement with MorphoSys 20
Takeda Expands Licensing Agreement With Genedata For Proteomics And Metabolomics Experiments 21
Genedata AG, Key Competitors 22
Genedata AG, Key Employees 23
Genedata AG, Subsidiaries 24

★海外企業調査レポート[Genedata AG-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Stena AB:企業の戦略的SWOT分析
    Stena AB - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Thi …
  • Epiroc AB (EPI A):企業の財務・戦略的SWOT分析
    Epiroc AB (EPI A) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Corcept Therapeutics Inc (CORT):企業の財務・戦略的SWOT分析
    Corcept Therapeutics Inc (CORT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Guess Inc (GES):企業の財務・戦略的SWOT分析
    Guess Inc (GES) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Ignyta Inc (RXDX)-医療機器分野:企業M&A・提携分析
    Summary Ignyta Inc (Ignyta), formerly NexDx Inc is a drug manufacturing company that discovers, develops and commercializes new drugs targeting activated genes in cancer cells for the treatment of cancer patients. The company develops products using integrated therapeutic (Rx) and companion diagnost …
  • Heinzel Holding GmbH:企業の戦略的SWOT分析
    Heinzel Holding GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • KDDI Corporation (9433):企業の財務・戦略的SWOT分析
    KDDI Corporation (9433) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Oramed Pharmaceuticals Inc (ORMP):企業の財務・戦略的SWOT分析
    Oramed Pharmaceuticals Inc (ORMP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Exact Holding N.V.:企業の戦略的SWOT分析
    Exact Holding N.V. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Einstein Noah Restaurant Group, Inc. (Foodservice):戦略・SWOT・企業財務分析
    Einstein Noah Restaurant Group, Inc. (Foodservice) - Strategy, SWOT and Corporate Finance Report Summary Einstein Noah Restaurant Group, Inc. (Foodservice) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's struct …
  • People’s Bank:企業の戦略・SWOT・財務情報
    People's Bank - Strategy, SWOT and Corporate Finance Report Summary People's Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • PayPoint plc:企業の戦略・SWOT・財務分析
    PayPoint plc - Strategy, SWOT and Corporate Finance Report Summary PayPoint plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • China Meheco Co Ltd:企業の戦略・SWOT・財務情報
    China Meheco Co Ltd - Strategy, SWOT and Corporate Finance Report Summary China Meheco Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • OncoSil Medical Ltd (OSL)-医療機器分野:企業M&A・提携分析
    Summary OncoSil Medical Ltd (OncoSil), formerly NeuroDiscovery Ltd is a medical device company that develops and commercializes treatments for patients with pancreatic and liver cancer. The company’s lead product include oncosil, a brachytherapy device that emits beta radiation and is implanted dire …
  • Dong Wha Pharma Co Ltd (000020):企業の財務・戦略的SWOT分析
    Summary Dong Wha Pharma Co Ltd (Dongwha Pharm) is a pharmaceutical company that offers generic products. The company offers ethical drugs, over-the-counter products, cosmetics, health foods, medical devices, and food and drinks. Its products comprise clzapine tablets, valaboom, aripico tablets, intr …
  • PT Sinar Mas Multiartha Tbk (SMMA):企業の財務・戦略的SWOT分析
    PT Sinar Mas Multiartha Tbk (SMMA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Green Highland Renewables Ltd:電力:M&Aディール及び事業提携情報
    Summary Green Highland Renewables Ltd (GHRL), formerly Green Highlander Renewables Limited, a subsidiary of Ancala Partners LLP, is a renewable energy company that develops, builds, and maintains hydro electric schemes. The company provides services including site identification, environmental appra …
  • Bank of Communications Ltd (601328):企業の財務・戦略的SWOT分析
    Bank of Communications Ltd (601328) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Showa Shell Sekiyu KK (5002):電力:M&Aディール及び事業提携情報
    Summary Showa Shell Sekiyu KK (Showa Shell) is an energy company. It mainly manufactures and sells oil products and energy related products, such as solar cell products and electricity. The company procures crude oil, refines, stores and sells petroleum products. Its product portfolio includes gasol …
  • Ergomed Plc (ERGO):企業の財務・戦略的SWOT分析
    Summary Ergomed Plc (Ergomed), formerly Ergomed Clinical Research Ltd, is a drug development and clinical research services provider. The company provides various services such as regulatory and quality management, biostatistics, study management, clinical data management, medical writing, and other …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆